A new drug aimed at preventing the early stages of Alzheimer’s disease has been created by scientists at Lancaster University. It’s hoped the research, which was funded by Alzheimer’s Research UK, could eventually lead to clinical trials to test the compound in people. The study is published in the journal PLoS ONE.
Potential Alzheimer’s treatment moves a step closer
Leave a reply